Tag Archives: Infinity Pharmaceuticals

Infinity Pharmaceuticals (INFI:NAS) and Orexigen Therapeutics (OREX:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
XNET Xunlei Ltd 3.220000 66183450 None 0.5273 3.69 None
MLNK ModusLink Global Solutions Inc 1.670000 55554589 None 1.3460 2.02 0.96
CXRX Concordia International Corp 1.620000 51089782 None None 6.58 -62.94
GURE Gulf Resources Inc 1.610000 46793791 1.9877 0.2095 3.69 3.64
INFI Infinity Pharmaceuticals Inc 1.410000 50443128 None 0.9639 1.50 1.11
VLRX Valeritas Holdings Inc 7.000000 6842978 4.9645 1.6346 7.48 2.64
OREX Orexigen Therapeutics Inc 2.890000 15227802 None 0.8756 5.03 -6.60
APWC Asia Pacific Wire & Cable Corp Ltd 3.025000 13819669 14.4048 0.3075 3.49 1.44
EVK Ever-Glory International Group Inc 2.650000 14792836 4.8182 0.4647 4.06 1.89
JRJC China Finance Online Co Ltd 1.510000 23619603 2.8118 0.4702 1.87 1.54
PRPH ProPhase Labs Inc 2.090000 16159796 2.4302 0.6665 2.65 2.65
ZAIS ZAIS Group Holdings Inc 2.300000 14680782 None 0.8245 3.05 -23.63
GIGM GigaMedia Ltd 3.030000 11052235 None 0.5655 5.91 5.67
CATB Catabasis Pharmaceuticals Inc 1.230000 22470062 None 1.1538 1.41 1.20
PRTO Proteon Therapeutics Inc 1.400000 17574371 None 0.7456 1.94 3.92
ABAC Aoxin Tianli Group Inc 2.659900 7983745 14.6667 0.2504 7.08 6.75
ATEC Alphatec Holdings Inc 1.730000 10857733 None None 2.35 -1.58
ANTH Anthera Pharmaceuticals Inc 1.490000 10079798 None 6.2946 2.05 0.26
GLBR Global Brokerage Inc 2.000000 6143305 0.9091 None 85.35 58.77
CREG China Recycling Energy Corp 1.340000 8310198 5.1538 0.0548 5.66 -0.20
TEAR TearLab Corp 1.650000 5735732 None None 2.27 -2.42
ROSG Rosetta Genomics Ltd 2.190000 2588086 None 1.2832 2.38 0.91
KBSF KBS Fashion Group Ltd 2.860000 1772016 None 0.0615 13.49 12.01
MDGS Medigus Ltd 2.326500 1992571 None 1.2673 4.23 None
NURO NeuroMetrix Inc 2.220000 1268465 None 0.3586 5.44 7.25

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

INFI:NAS Infinity Pharmaceuticals

http://www.infi.com
Infinity Pharmaceuticals has 23 employees and is headquartered in United States.
Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing and delivering medicines to people with difficult-to-treat diseases.

OREX:NAS Orexigen Therapeutics

http://www.orexigen.com
Orexigen Therapeutics has 132 employees and is headquartered in United States.
Orexigen Therapeutics Inc is an emerging pharmaceutical company. The company is developing neuroscience drugs that will ultimately address obesity and weight related medical issues.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.